Prague in April; NATA Symposium - Blood Management
A new invitation from NATA...
Areas of interest :
Blood Procurement and Transfusion Risks
Optimising the Practice of Transfusion
Management of the Bleeding Patient
Iron Therapy and Patient Blood Management
Burning Questions on Haemostasis and Thrombosis
Pro/Con Debate: Using a Fixed RBC:FFP:PLT Ratio in Massively Bleeding Patients.
Four practical workshops, each repeated twice, will provide an excellent opportunity for clinical discussions and exchange of experience:
Management of Massive Bleeding
Management of Patients on Oral Anticoagulants
Cell Salvage for the Inexperienced—An Overview of the Available Technologies
How to Set Up a Clinical Trial in Transfusion Medicine.
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%) 47,XY,del(5) (q22q35),+21[cp24]/46,XY(1).
|Thread Tools||Search this Thread|